Tailored radiotherapy for brain metastases improves precision and outcomes

Area of Science:

• Oncology
• Radiation Oncology
• Neuro-oncology

Background:

• Brain metastases are a major challenge in cancer care, often leading to poor prognosis.
• Traditional whole-brain radiation therapy (WBRT) has limitations in precision and side effect profile.

Purpose of the Study:

• To review the evolving landscape of brain metastases management.
• To highlight the integration of modern radiotherapy, systemic therapies, and prognostic tools.

Main Methods:

• Literature review synthesizing current evidence on brain metastases treatment.
• Emphasis on stereotactic radiosurgery (SRS), surgical resection, targeted therapies, and immunotherapies.
• Discussion of prognostic tools like the Graded Prognostic Assessment (GPA).

Main Results:

• Shift from WBRT to more precise modalities like SRS and surgery for select patients.
• Systemic therapies (targeted/immuno) are transforming treatment for specific cancers (melanoma, NSCLC).
• Prognostic tools aid in tailoring treatment based on patient status and disease characteristics.

Conclusions:

• A multidisciplinary, personalized approach is essential for optimizing outcomes and quality of life.
• Advances in radiotherapy and systemic treatments offer improved management strategies.
• Future directions focus on evidence-based, tailored interventions for brain metastases.